IPC issues alert on painkiller drug nimesulide over adverse reaction

Contact Counsellor

Last Updated13/04/2024

Pharma standards body Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert over nimesulide, saying the pill can trigger rashes on the skin (fixed drug eruption).
It asked consumers and healthcare professionals to closely monitor the use of the drug and report any adverse reaction to the National Coordination Centre-Pharmacovigilance Programme of India of the IPC.

It is an autonomous Institution of the Ministry of Health and Family Welfare, Government of India.
It is created to set standards of drugs in the country.
Its basic function is to regularly update the standards of drugs commonly required for the treatment of diseases prevailing in this region.
It publishes official documents for improving the Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).
It further promotes the rational use of generic medicines by publishing the National Formulary of India.
It prescribes standards for identity, purity and strength of drugs essentially required from the health care perspective of human beings and animals.
It also provides IP Reference Substances(IPRS) which act as a fingerprint for identification of an article under test and its purity as prescribed in IP.